Select Medical (NYSE:SEM) Lowered to Hold Rating by StockNews.com

StockNews.com lowered shares of Select Medical (NYSE:SEM) from a buy rating to a hold rating in a research note published on Monday morning.

A number of other brokerages have also recently issued reports on SEM. Benchmark cut shares of Select Medical from a “buy” rating to a “hold” rating in a report on Monday, November 25th. Royal Bank of Canada upped their target price on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th.

Select Medical Trading Down 1.0 %

NYSE SEM opened at $18.80 on Monday. The stock has a market capitalization of $2.43 billion, a PE ratio of 8.79, a price-to-earnings-growth ratio of 0.39 and a beta of 1.43. The firm has a 50 day moving average of $28.01 and a two-hundred day moving average of $32.62. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical has a 52 week low of $18.02 and a 52 week high of $40.98.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.07. Select Medical had a return on equity of 15.99% and a net margin of 3.97%. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same quarter last year, the company posted $0.46 earnings per share. The business’s quarterly revenue was up 5.7% compared to the same quarter last year. As a group, research analysts expect that Select Medical will post 1.97 EPS for the current fiscal year.

Select Medical Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Wednesday, November 13th were given a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a dividend yield of 2.66%. The ex-dividend date of this dividend was Wednesday, November 13th. Select Medical’s dividend payout ratio is currently 23.36%.

Insiders Place Their Bets

In other news, Director Marilyn B. Tavenner sold 32,000 shares of the company’s stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $21.09, for a total transaction of $674,880.00. Following the completion of the transaction, the director now owns 22,000 shares in the company, valued at approximately $463,980. This represents a 59.26 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the firm’s stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $19.95, for a total transaction of $99,530.55. Following the completion of the sale, the vice president now owns 30,356 shares in the company, valued at $605,602.20. The trade was a 14.12 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is currently owned by corporate insiders.

Institutional Trading of Select Medical

Several large investors have recently added to or reduced their stakes in the business. Point72 Asset Management L.P. grew its stake in shares of Select Medical by 144.2% in the third quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock worth $71,825,000 after purchasing an additional 1,216,263 shares in the last quarter. Millennium Management LLC grew its position in Select Medical by 183.9% in the 2nd quarter. Millennium Management LLC now owns 679,522 shares of the health services provider’s stock valued at $23,824,000 after buying an additional 440,140 shares in the last quarter. Hood River Capital Management LLC acquired a new position in Select Medical during the 2nd quarter valued at about $14,819,000. Loomis Sayles & Co. L P bought a new stake in shares of Select Medical during the 3rd quarter worth about $9,710,000. Finally, LMR Partners LLP bought a new position in shares of Select Medical in the third quarter valued at approximately $6,139,000. 89.48% of the stock is currently owned by institutional investors and hedge funds.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.